nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—polycystic ovary syndrome	0.937	1	CbGaD
Pefloxacin—TOP2A—Gastric Cancer Network 1—S100P—polycystic ovary syndrome	0.00849	0.166	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.00372	0.0727	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00353	0.069	CbGpPWpGaD
Pefloxacin—TOP2A—G0 and Early G1—CCNE2—polycystic ovary syndrome	0.00268	0.0524	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.00267	0.0523	CbGpPWpGaD
Pefloxacin—TOP2A—G0 and Early G1—CDC6—polycystic ovary syndrome	0.00252	0.0493	CbGpPWpGaD
Pefloxacin—CYP1A2—urine—polycystic ovary syndrome	0.0015	0.27	CbGeAlD
Pefloxacin—Enoxacin—TOP2A—polycystic ovary syndrome	0.00146	0.223	CrCbGaD
Pefloxacin—TOP2A—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00137	0.0267	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.00114	0.0224	CbGpPWpGaD
Pefloxacin—Lomefloxacin—TOP2A—polycystic ovary syndrome	0.00111	0.169	CrCbGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.000989	0.0193	CbGpPWpGaD
Pefloxacin—Levofloxacin—TOP2A—polycystic ovary syndrome	0.000947	0.144	CrCbGaD
Pefloxacin—Ofloxacin—TOP2A—polycystic ovary syndrome	0.000947	0.144	CrCbGaD
Pefloxacin—Ciprofloxacin—TOP2A—polycystic ovary syndrome	0.000915	0.139	CrCbGaD
Pefloxacin—Norfloxacin—TOP2A—polycystic ovary syndrome	0.000768	0.117	CrCbGaD
Pefloxacin—TOP2A—endometrium—polycystic ovary syndrome	0.000741	0.133	CbGeAlD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000726	0.0142	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.000718	0.014	CbGpPWpGaD
Pefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000698	0.0137	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000696	0.0136	CbGpPWpGaD
Pefloxacin—TOP2A—uterus—polycystic ovary syndrome	0.000683	0.123	CbGeAlD
Pefloxacin—TOP2A—adipose tissue—polycystic ovary syndrome	0.000668	0.12	CbGeAlD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.000667	0.013	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000654	0.0128	CbGpPWpGaD
Pefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000635	0.0124	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000614	0.012	CbGpPWpGaD
Pefloxacin—TOP2A—adrenal gland—polycystic ovary syndrome	0.000599	0.108	CbGeAlD
Pefloxacin—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000568	0.0111	CbGpPWpGaD
Pefloxacin—TOP2A—female gonad—polycystic ovary syndrome	0.000559	0.1	CbGeAlD
Pefloxacin—TOP2A—vagina—polycystic ovary syndrome	0.000555	0.0999	CbGeAlD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.00055	0.0108	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000511	0.00999	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000473	0.00926	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00047	0.00919	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000444	0.00869	CbGpPWpGaD
Pefloxacin—Norfloxacin—CYP1A1—polycystic ovary syndrome	0.000411	0.0627	CrCbGaD
Pefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000401	0.00784	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000397	0.00777	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000393	0.0077	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000387	0.00757	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000365	0.00714	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000344	0.00673	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000337	0.00658	CbGpPWpGaD
Pefloxacin—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000335	0.00656	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000323	0.00631	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000291	0.00568	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000281	0.00551	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000273	0.00534	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000257	0.00502	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000256	0.005	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000255	0.00499	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000253	0.00495	CbGpPWpGaD
Pefloxacin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000249	0.0448	CbGeAlD
Pefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000249	0.00487	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.00024	0.00469	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000235	0.00459	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000232	0.00453	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000228	0.00446	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00022	0.0043	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000218	0.00427	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000216	0.00422	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000215	0.00421	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000215	0.0042	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000214	0.00418	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000212	0.00416	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000195	0.00382	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00019	0.00372	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000187	0.00366	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000177	0.00346	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000177	0.00346	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000177	0.00346	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000175	0.00342	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000173	0.00338	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000172	0.00337	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000172	0.00337	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000172	0.00337	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000171	0.00334	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000167	0.00328	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000166	0.00324	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000164	0.00322	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000161	0.00315	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000158	0.00309	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000152	0.00298	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00015	0.00294	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.000147	0.00288	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000142	0.00278	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00014	0.00274	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000139	0.00272	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000137	0.00269	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000137	0.00268	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000131	0.00257	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000127	0.00248	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000122	0.00239	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000114	0.00223	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000113	0.00221	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000113	0.0022	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000108	0.00212	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000104	0.00203	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000101	0.00198	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	9.98e-05	0.00195	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	9.83e-05	0.00192	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.42e-05	0.00184	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.4e-05	0.00184	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.27e-05	0.00181	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	8.57e-05	0.00168	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	8.57e-05	0.00168	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.42e-05	0.00165	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	8.07e-05	0.00158	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.44e-05	0.00146	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.34e-05	0.00144	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.18e-05	0.0014	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	6.8e-05	0.00133	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	6.53e-05	0.00128	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.49e-05	0.00127	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	6e-05	0.00117	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.92e-05	0.00116	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.52e-05	0.00108	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	5.28e-05	0.00103	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.03e-05	0.000984	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.92e-05	0.000962	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	4.83e-05	0.000944	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	4.83e-05	0.000944	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.76e-05	0.000932	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	4.49e-05	0.000877	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	4.47e-05	0.000875	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.38e-05	0.000858	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.09e-05	0.000801	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.88e-05	0.00076	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	3.81e-05	0.000746	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	3.81e-05	0.000746	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.67e-05	0.000717	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.61e-05	0.000706	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.2e-05	0.000625	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.03e-05	0.000593	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.89e-05	0.000565	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.86e-05	0.000559	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.58e-05	0.000504	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.46e-05	0.000481	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.43e-05	0.000475	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.3e-05	0.000451	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.24e-05	0.000438	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.19e-05	0.000429	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.12e-05	0.000415	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.95e-05	0.000382	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.89e-05	0.00037	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.82e-05	0.000357	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.75e-05	0.000343	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.74e-05	0.000341	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.73e-05	0.000338	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.72e-05	0.000336	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.63e-05	0.00032	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.61e-05	0.000315	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.39e-05	0.000272	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.35e-05	0.000265	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.27e-05	0.000249	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.14e-05	0.000222	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.08e-05	0.000212	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.03e-05	0.000201	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	9.56e-06	0.000187	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	7.75e-06	0.000152	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	7.65e-06	0.00015	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	7.61e-06	0.000149	CbGpPWpGaD
